Germline variants associated with toxicity to immune checkpoint blockade

Stefan Groha(Broad Institute), Sarah Abou Alaiwi(Brigham and Women's Hospital), Wenxin Xu(Harvard University), Vivek Naranbhai(Harvard University), Amin H. Nassar(Brigham and Women's Hospital), Ziad Bakouny(Brigham and Women's Hospital), Talal El Zarif(Harvard University), Renée Maria Saliby(Harvard University), Guihong Wan(Harvard University), Ahmad Rajeh(Massachusetts General Hospital), Elio Adib(Brigham and Women's Hospital), Pier Vitale Nuzzo(Dana-Farber Cancer Institute), Andrew Schmidt(Harvard University), Chris Labaki(Harvard University), Biagio Ricciuti(Dana-Farber Cancer Institute), Joao V. Alessi(University of Genoa), David A. Braun(Yale Cancer Center), Sachet A. Shukla(Broad Institute), Tanya E. Keenan(Broad Institute), Eliezer M. Van Allen(Broad Institute), Mark M. Awad(University of Genoa), Michael P. Manos(Harvard University), Osama E. Rahma(Brigham and Women's Hospital), Leyre Zubiri(Massachusetts General Hospital), Alexandra–Chloé Villani(Broad Institute), Benjamin P. Fairfax(University of Oxford), Christian Hammer, Zia Khan, Kerry L. Reynolds(Harvard University), Yevgeniy R. Semenov(Harvard University), Deborah Schrag(Dana-Farber Cancer Institute), Kenneth L. Kehl(Dana-Farber Cancer Institute), Matthew L. Freedman(Broad Institute), Toni K. Choueiri(Brigham and Women's Hospital), Alexander Gusev(Broad Institute)
Nature Medicine
December 1, 2022
Cited by 106

Abstract


Related Papers

No related papers found

Powered by citation graph analysis